Regeneron Announces Updates to Board of Directors : comparem

Kathryn Guarini, Ph.D., and David P. Schenkein, M.D., join Regeneron’s Board of Directors...

Related Keywords

United States , American , Georged Yancopoulos , Davidp Schenkein , Marc Tessier Lavigne , Christine Poon , Mark Hudson , Leonards Schleifer , Alexandra Bowie , Kathryn Guarini , Agios Pharmaceuticals Inc , Denali Therapeutics Inc , Nasdaq , Hematology Oncology At Tufts Medical Center , Clinical Hematology Oncology At Genentech Inc , Regeneron Genetics Center , Board Co , Yale University , Regeneron Pharmaceuticals Inc , Stanford University , Technology Magazine , Board Member Of Prime Medicine Inc , Ibm , Clinical Research At Millennium Pharmaceuticals Inc , Life Sciences , Tufts University School Of Medicine , Lead Independent Director , Independent Director , Chief Information Officer , Chief Operating Officer , Vice President , Product Management , United States Patent , Trademark Office , National Council , Expanding American , Applied Physics , General Partner , Google Ventures , Chief Executive Officer , Agios Pharmaceuticals , Senior Vice President , Clinical Research , Millennium Pharmaceuticals , Adjunct Clinical Professor , Tufts Medical , Board Member , Prime Medicine , Denali Therapeutics , State University , New York Upstate Medical School , Tufts University School , Board Co Chair , Chief Scientific Officer , Regeneron Genetics , Nasdaq Regn , Regeneron Pharmaceuticals , Nc , Biotech , Regeneron , Board Of Directors , Financial ,